Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Blood. 2021 Jan 21;137(3):323-335. doi: 10.1182/blood.2020006770.
Blood. 2021.
PMID: 32967009
Free PMC article.
Clinical Trial.
Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager.
Crook ZR, Girard EJ, Sevilla GP, Brusniak MY, Rupert PB, Friend DJ, Gewe MM, Clarke M, Lin I, Ruff R, Pakiam F, Phi TD, Bandaranayake A, Correnti CE, Mhyre AJ, Nairn NW, Strong RK, Olson JM.
Crook ZR, et al. Among authors: phi td.
Sci Transl Med. 2022 May 18;14(645):eabn0402. doi: 10.1126/scitranslmed.abn0402. Epub 2022 May 18.
Sci Transl Med. 2022.
PMID: 35584229
Free PMC article.
Item in Clipboard
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy.
Godwin CD, Laszlo GS, Fiorenza S, Garling EE, Phi TD, Bates OM, Correnti CE, Hoffstrom BG, Lunn MC, Humbert O, Kiem HP, Turtle CJ, Walter RB.
Godwin CD, et al. Among authors: phi td.
Leukemia. 2021 Sep;35(9):2496-2507. doi: 10.1038/s41375-021-01160-1. Epub 2021 Feb 15.
Leukemia. 2021.
PMID: 33589747
Free PMC article.
Item in Clipboard
CYpHER: Catalytic extracellular targeted protein degradation with high potency and durable effect.
Crook ZR, Sevilla GP, Young P, Girard EJ, Phi TD, Howard M, Price J, Olson JM, Nairn NW.
Crook ZR, et al. Among authors: phi td.
bioRxiv [Preprint]. 2024 Apr 23:2024.02.21.581471. doi: 10.1101/2024.02.21.581471.
bioRxiv. 2024.
PMID: 38712232
Free PMC article.
Preprint.
Item in Clipboard
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.
Gauthier J, Hirayama AV, Purushe J, Hay KA, Lymp J, Li DH, Yeung CCS, Sheih A, Pender BS, Hawkins RM, Vakil A, Phi TD, Steinmetz RN, Shadman M, Riddell SR, Maloney DG, Turtle CJ.
Gauthier J, et al. Among authors: phi td.
Blood. 2020 May 7;135(19):1650-1660. doi: 10.1182/blood.2019002936.
Blood. 2020.
PMID: 32076701
Free PMC article.
Item in Clipboard
Cite
Cite